Found: 92
Select item for more details and to access through your institution.
The Prognostic Value of ASPHD1 and ZBTB12 in Colorectal Cancer: A Machine Learning-Based Integrated Bioinformatics Approach.
- Published in:
- Cancers, 2023, v. 15, n. 17, p. 4300, doi. 10.3390/cancers15174300
- By:
- Publication type:
- Article
Carboplatin Dosing in Children Using Estimated Glomerular Filtration Rate: Equation Matters.
- Published in:
- Cancers, 2021, v. 13, n. 23, p. 5963, doi. 10.3390/cancers13235963
- By:
- Publication type:
- Article
Cyclin Dependent Kinase-1 (CDK-1) Inhibition as a Novel Therapeutic Strategy against Pancreatic Ductal Adenocarcinoma (PDAC).
- Published in:
- Cancers, 2021, v. 13, n. 17, p. 4389, doi. 10.3390/cancers13174389
- By:
- Publication type:
- Article
High Temperature Drives Topoisomerase Mediated Chromosomal Break Repair Pathway Choice.
- Published in:
- Cancers, 2021, v. 13, n. 10, p. 2315, doi. 10.3390/cancers13102315
- By:
- Publication type:
- Article
An Evaluation of the Diagnostic Accuracy of a Panel of Variants in DPYD and a Single Variant in ENOSF1 for Predicting Common Capecitabine Related Toxicities.
- Published in:
- Cancers, 2021, v. 13, n. 7, p. 1497, doi. 10.3390/cancers13071497
- By:
- Publication type:
- Article
Epithelial Transfer of the Tyrosine Kinase Inhibitors Erlotinib, Gefitinib, Afatinib, Crizotinib, Sorafenib, Sunitinib, and Dasatinib: Implications for Clinical Resistance.
- Published in:
- Cancers, 2020, v. 12, n. 11, p. 3322, doi. 10.3390/cancers12113322
- By:
- Publication type:
- Article
"Open Sesame?": Biomarker Status of the Human Equilibrative Nucleoside Transporter-1 and Molecular Mechanisms Influencing its Expression and Activity in the Uptake and Cytotoxicity of Gemcitabine in Pancreatic Cancer.
- Published in:
- Cancers, 2020, v. 12, n. 11, p. 3206, doi. 10.3390/cancers12113206
- By:
- Publication type:
- Article
Kinase Inhibitor Treatment of Patients with Advanced Cancer Results in High Tumor Drug Concentrations and in Specific Alterations of the Tumor Phosphoproteome.
- Published in:
- Cancers, 2020, v. 12, n. 2, p. 330, doi. 10.3390/cancers12020330
- By:
- Publication type:
- Article
Role of c-MET Inhibitors in Overcoming Drug Resistance in Spheroid Models of Primary Human Pancreatic Cancer and Stellate Cells.
- Published in:
- Cancers, 2019, v. 11, n. 5, p. 638, doi. 10.3390/cancers11050638
- By:
- Publication type:
- Article
Transporter and Lysosomal Mediated (Multi)drug Resistance to Tyrosine Kinase Inhibitors and Potential Strategies to Overcome Resistance.
- Published in:
- Cancers, 2018, v. 10, n. 12, p. 503, doi. 10.3390/cancers10120503
- By:
- Publication type:
- Article
The relation between deoxycytidine kinase activity and the radiosensitising effect of gemcitabine in eight different human tumour cell lines.
- Published in:
- BMC Cancer, 2006, v. 6, p. 142, doi. 10.1186/1471-2407-6-142
- By:
- Publication type:
- Article
Thiopurines with low-dose allopurinol (ThiLDA)—a prospective clinical one-way crossover trial.
- Published in:
- European Journal of Clinical Pharmacology, 2019, v. 75, n. 12, p. 1669, doi. 10.1007/s00228-019-02760-8
- By:
- Publication type:
- Article
High-Dose 5-Fluorouracil with Uridine-Diphosphoglucose Rescue Increases Thymidylate Synthase Inhibition but Not 5-Fluorouracil Incorporation into RNA in Murine Tumors.
- Published in:
- Oncology, 2002, v. 62, n. 4, p. 363, doi. 10.1159/000065069
- By:
- Publication type:
- Article
Positron emission tomography using 2-deoxy-2-[<sup>18</sup>F]-fluoro-D-glucose for response monitoring in locally advanced gastroesophageal cancer; a comparison of different analytical methods
- Published in:
- 2003
- By:
- Publication type:
- journal article
hENT-1 Expression and Localization Predict Outcome After Adjuvant Gemcitabine in Resected Cholangiocarcinoma Patients.
- Published in:
- 2016
- By:
- Publication type:
- Letter to the Editor
Platinum-Induced Neurotoxicity and Preventive Strategies: Past, Present, and Future.
- Published in:
- Oncologist, 2015, v. 20, n. 4, p. 411, doi. 10.1634/theoncologist.2014-0044
- By:
- Publication type:
- Article
Alternative scheduling of pulsatile, high dose sunitinib efficiently suppresses tumor growth.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2016, v. 35, p. 1, doi. 10.1186/s13046-016-0411-2
- By:
- Publication type:
- Article
A New Oxadiazole-Based Topsentin Derivative Modulates Cyclin-Dependent Kinase 1 Expression and Exerts Cytotoxic Effects on Pancreatic Cancer Cells.
- Published in:
- Molecules, 2022, v. 27, n. 1, p. 19, doi. 10.3390/molecules27010019
- By:
- Publication type:
- Article
3-(6-Phenylimidazo [2,1-b][1,3,4]thiadiazol-2-yl)-1H-Indole Derivatives as New Anticancer Agents in the Treatment of Pancreatic Ductal Adenocarcinoma.
- Published in:
- Molecules, 2020, v. 25, n. 2, p. 329, doi. 10.3390/molecules25020329
- By:
- Publication type:
- Article
CX-5461 Inhibits Pancreatic Ductal Adenocarcinoma Cell Growth, Migration and Induces DNA Damage.
- Published in:
- Molecules, 2019, v. 24, n. 24, p. 4445, doi. 10.3390/molecules24244445
- By:
- Publication type:
- Article
The Role of c-Met as a Biomarker and Player in Innate and Acquired Resistance in Non-Small-Cell Lung Cancer: Two New Mutations Warrant Further Studies.
- Published in:
- Molecules, 2019, v. 24, n. 24, p. 4443, doi. 10.3390/molecules24244443
- By:
- Publication type:
- Article
Double Trouble: A Case Series on Concomitant Genetic Aberrations in NSCLC.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The role of l-leucovorin uptake and metabolism in the modulation of 5-fluorouracil efficacy and antifolate toxicity.
- Published in:
- Frontiers in Pharmacology, 2024, p. 01, doi. 10.3389/fphar.2024.1450418
- By:
- Publication type:
- Article
Adherence and Patients' Experiences with the Use of Capecitabine in Daily Practice.
- Published in:
- Frontiers in Pharmacology, 2016, p. 1, doi. 10.3389/fphar.2016.00310
- By:
- Publication type:
- Article
The use of capecitabine in daily practice: a study on adherence and patients' experiences.
- Published in:
- Patient Preference & Adherence, 2012, v. 6, p. 741, doi. 10.2147/PPA.S36757
- By:
- Publication type:
- Article
Therapeutic potential of TAS-102 in the treatment of gastrointestinal malignancies.
- Published in:
- Therapeutic Advances in Medical Oncology, 2015, v. 7, n. 6, p. 340, doi. 10.1177/1758834015603313
- By:
- Publication type:
- Article
The allosteric AKT inhibitor MK2206 shows a synergistic interaction with chemotherapy and radiotherapy in glioblastoma spheroid cultures.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Role of CYB5A in Pancreatic Cancer Prognosis and Autophagy Modulation.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 1, p. 1, doi. 10.1093/jnci/djt346
- By:
- Publication type:
- Article
Exploring the role of oxidative stress and the effect of N‐acetylcysteine in thiopurine‐induced liver injury in inflammatory bowel disease: A randomized crossover pilot study.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2024, v. 134, n. 4, p. 507, doi. 10.1111/bcpt.13978
- By:
- Publication type:
- Article
Novel insights in folate receptors and transporters: implications for disease and treatment of immune diseases and cancer.
- Published in:
- Pteridines, 2015, v. 26, n. 2, p. 41, doi. 10.1515/pterid-2015-0005
- By:
- Publication type:
- Article
Folate homeostasis of cancer cells affects sensitivity to not only antifolates but also other non-folate drugs: effect of MRP expression.
- Published in:
- Pteridines, 2013, v. 24, n. 1, p. 81, doi. 10.1515/pterid-2013-0019
- By:
- Publication type:
- Article
Thymidylate synthase inhibitors for thoracic tumors.
- Published in:
- Pteridines, 2013, v. 24, n. 1, p. 57, doi. 10.1515/pterid-2013-0018
- By:
- Publication type:
- Article
Polymorphisms correlated with the clinical outcome of locally advanced or metastatic colorectal cancer patients treated with ALIRI vs. FOLFIRI.
- Published in:
- Pteridines, 2013, v. 24, n. 1, p. 69, doi. 10.1515/pterid-2013-0021
- By:
- Publication type:
- Article
G-Protein Signaling Modulator 2 as a Potential Biomarker in Colorectal Cancer: Integrative Analysis Using Genetic Profiling and Pan-Cancer Studies.
- Published in:
- Genes, 2024, v. 15, n. 4, p. 474, doi. 10.3390/genes15040474
- By:
- Publication type:
- Article
Comment on: Targeting the HGF/c-MET pathway in advanced pancreatic cancer: a key element of treatment that limits primary tumour growth and eliminates metastasis.
- Published in:
- 2020
- By:
- Publication type:
- letter
Cytidine deaminase enzymatic activity is a prognostic biomarker in gemcitabine/platinum-treated advanced non-small-cell lung cancer: a prospective validation study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Pharmacologically directed strategies in academic anticancer drug discovery based on the European NCI compounds initiative.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Exploring Splicing Modulation as an Innovative Approach to Combat Pancreatic Cancer: SF3B1 Emerges as a Prognostic Indicator and Therapeutic Target.
- Published in:
- International Journal of Biological Sciences, 2024, v. 20, n. 9, p. 3173, doi. 10.7150/ijbs.92671
- By:
- Publication type:
- Article
Exploring Splicing Modulation as an Innovative Approach to Combat Pancreatic Cancer: SF3B1 Emerges as a Prognostic Indicator and Therapeutic Target.
- Published in:
- International Journal of Biological Sciences, 2024, v. 20, n. 8, p. 3173, doi. 10.7150/ijbs.92671
- By:
- Publication type:
- Article
A single nucleotide polymorphism in EZH2 predicts overall survival rate in patients with cholangiocarcinoma.
- Published in:
- Oncology Letters, 2013, v. 6, n. 5, p. 1487, doi. 10.3892/ol.2013.1559
- By:
- Publication type:
- Article
Severe toxicity of capecitabine following uncomplicated treatment with 5-fluorouracil/leucovorin.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Polymorphisms in the Enhancer Region of the Thymidylate Synthase Gene Are Associated with Thymidylate Synthase Levels in Normal Tissues but Not in Malignant Tissues of Patients with Colorectal Cancer.
- Published in:
- Clinical Colorectal Cancer, 2009, v. 8, n. 3, p. 146, doi. 10.3816/CCC.2009.n.024
- By:
- Publication type:
- Article
NUC-1031 in biliary tract cancer: from bench to bedside and back?
- Published in:
- 2020
- By:
- Publication type:
- editorial
Cellular pharmacology studies of anticancer agents: recommendations from the EORTC-PAMM group.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The potential of multi-compound nanoparticles to bypass drug resistance in cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Pharmacokinetics and pharmacogenetics of Gemcitabine as a mainstay in adult and pediatric oncology: an EORTC-PAMM perspective.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Contemporary reviews on cancer treatment.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Can cytidine deaminase be used as predictive biomarker for gemcitabine toxicity and response?
- Published in:
- British Journal of Clinical Pharmacology, 2019, v. 85, n. 6, p. 1213, doi. 10.1111/bcp.13921
- By:
- Publication type:
- Article
Addition of leucovorin in modulation of 5-fluorouracil with methotrexate: Potentiating or reversing effect?
- Published in:
- International Journal of Cancer, 1995, v. 61, n. 5, p. 672, doi. 10.1002/ijc.2910610514
- By:
- Publication type:
- Article
The effect of schedule, protein binding and growth factors on the activity of suramin.
- Published in:
- International Journal of Cancer, 1992, v. 51, n. 6, p. 921, doi. 10.1002/ijc.2910510615
- By:
- Publication type:
- Article